Analyst consensus rating
Minerva Neurosciences Analyst Rating: Buy
NERV is rated Buy by 3 analysts with a $10.33 target. As of 2026-08-29.
Direct answer
Minerva Neurosciences's consensus rating is Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.33.
Forecast evidence checked August 29, 2026.
Get free Minerva Neurosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.84
- Average price target
- $10.33
- High price target
- $14.00
- Low price target
- $7.00
- Low target gap
- +44.6%
- Target upside
- +113.5%
- High target gap
- +189.3%
- Target range width
- 144.6%
- Consensus rating
- Buy
- Analysts
- 3
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Minerva Neurosciences?
Minerva Neurosciences has a verified Buy consensus. The same dataset has an average price target of $10.33.
How far are Minerva Neurosciences's low and high targets from the recorded price?
The low target implies +44.6%, while the high target implies +189.3%.
How many analysts are included in Minerva Neurosciences's consensus?
The verified consensus includes 3 analysts.
How is Minerva Neurosciences's target upside or downside calculated?
The average target of $10.33 is divided by the recorded price of $4.84, then one is subtracted to produce +113.5%. This does not guarantee a future return.
When was Minerva Neurosciences's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.